After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the other two
Categories
pharma stocks
Mallinckrodt soars 10% on strong Q3
Pharmaceutical company Mallinckrodt plc (MNK) Tuesday reported third-quarter results that topped analysts’ estimates, sending its shares up 10% during pre-market hours. Earnings
Abbott posts strong Q3 results, narrows full year outlook
Pharmaceutical giant Abbott Laboratories (ABT) delivered a 12% increase in third-quarter revenue to $7.7 billion, helped by a 43% increase in diagnostics
Pharmaceuticals unit lifts Johnson & Johnson results in Q3
Medical devices giant Johnson & Johnson (JNJ) reported higher revenue and income in Q3, driven by strong sales of pharmaceuticals products. The
Three pharma stocks to buy and hold this quarter
Healthcare and pharma companies hold a lot of promise in the present landscape, where most countries have high aging demographics. Though some
Johnson & Johnson under the scanner in India over “faulty” hip replacement devices
An experts’ panel framed by India’s Ministry of Health has found that Johnson & Johnson (JNJ) suppressed facts relating to its “faulty”
Eylea lifts Regeneron Q2 earnings
Regeneron Pharmaceuticals Thursday reported better-than-expected second quarter earnings of $5.45 per share on a revenue of $1.6 billion. Revenue for the quarter
AbbVie’s elagolix meet phase III trial target
Among the pharma stocks, AbbVie (ABBV) is a company that has got an impressive reputation for growing demand for its drugs, new